X-PACT Now Immunolight Cancer Therapy (ICT)

We are thrilled to announce a significant milestone in our ongoing mission to provide advanced and effective treatments for cancer patients. Our groundbreaking cancer treatment, formerly known as X-PACT, has been rebranded as Immunolight Cancer Therapy (ICT).

This new name reflects our unwavering commitment to light-based innovation in cancer treatment. ICT represents a new era in oncological care, emphasizing our dedication to harnessing the power of light to advance cancer therapies.

ICT continues to embody the pioneering spirit that has driven our research and development efforts. This evolution in our brand identity underscores our commitment to providing patients with cutting-edge treatments that are both effective and life-changing.

Previous
Previous

Harnessing the Power of Light

Next
Next

Immunolight Selected to Present at 2024 Future in Review Conference